From: Phenotyping diabetic cardiomyopathy in Europeans and South Asians
 | T2D (n = 48) | Controls (n = 29) |
---|---|---|
LV diastolic function | ||
 E, mL/s | 326 ± 97 | 352 ± 55 |
 A, mL/s | 366 ± 71* | 301 ± 75 |
 E/A ratio | 0.93 ± 0.38* | 1.24 ± 0.36 |
 E dec peak, mL/s2 ×10−3 | − 2.7 ± 1.0* | − 3.2 ± 0.7 |
 Ea, cm/s | 5.9 ± 1.7* | 7.7 ± 1.9 |
 Estimate of LV filling pressure, mmHg | 7.6 ± 2.6* | 5.1 ± 1.7 |
 Estimate of LV compliance, mL/mmHg | 21.3 ± 9.4* | 33.4 ± 11.2 |
 GLSR-E, 1/s | 0.78 ± 0.23 | 0.87 ± 0.28 |
 GCSR-E, 1/s | 1.15 ± 0.37 | 1.22 ± 0.37 |
LV systolic function | ||
 Ejection fraction, % | 55 ± 5 | 56 ± 6 |
 GLS, % | − 19.3 ± 2.7* | − 21.1 ± 3.3 |
 GCS, % | − 26.1 ± 4.5 | − 26.5 ± 3.9 |
Hemodynamics | ||
 Stroke volume, mL | 78 ± 17* | 88 ± 17 |
 Cardiac output, L/min | 5.4 ± 1.0 | 5.2 ± 1.1 |
 Cardiac index, L/min/m2 | 2.5 ± 0.4* | 2.7 ± 0.5 |
Aortic stiffness | ||
 Aortic pulse wave velocity, m/s | 8.5 ± 2.2* | 7.5 ± 1.5 |
LV structure | ||
 End-diastolic volume, mL | 142 ± 29* | 156 ± 26 |
 Mass, g | 107 ± 23 | 96 ± 24 |
 Concentricity, g/mL | 0.76 ± 0.12* | 0.61 ± 0.09 |
Myocardial tissue characteristics | ||
 Myocardial Tg content, % | 1.19 ± 0.53* | 0.58 ± 0.18 |
 Native T1, ms | 1197 ± 44* | 1230 ± 28 |
 Extracellular volume fraction, % | 26.3 ± 2.5 | 26.9 ± 2.7 |
 Extracellular volume, mL | 27 ± 6 | 24 ± 5 |
 Cell volume, mL | 75 ± 18 | 67 ± 18 |